Sign inJoin waitlistJoin the waitlist

MC

Maureen Cooper

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
1990–1993
Internal Medicine
1987–1990
Rush Medical College
1983–1987

Research

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
Blood · 2014 · 285 citations
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients
Clinical Cancer Research · 2003 · 263 citations
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes
Blood · 2003 · 168 citations

FG
Francis Giles
4 papers
Hagop Kantarjian
4 papers
JL
Jeffrey Lancet
4 papers
MA
Maher Albitar
4 papers
Alison Stopeck
3 papers
SO
Susan O'Brien
3 papers
Ajay Gopal
2 papers
BC
Brian Caveney
2 papers
EF
Eric Feldman
2 papers
ES
Eric Severson
2 papers
Guillermo Garcia-Manero
2 papers
HK
Heidi Ko
2 papers